ITAREPS relapse prevention in schizophrenia

International Journal of Clinical Practice

Volumn 62, Issue 12, 2008, Pages 1824-1825

  Volavka, J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE SEVERITY; EDITORIAL; FAMILY; HOSPITALIZATION; HUMAN; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOPHARMACOLOGY; QUESTIONNAIRE; RELAPSE; SCHIZOPHRENIA; TELEPHONE; TREATMENT OUTCOME;

HUMANS; RECURRENCE; SCHIZOPHRENIA;

EID: 55949098702     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01928.x     Document Type: Editorial

References (5)

1. Španiel F, Vohlídka P, Kožený J et al. The Information Technology Aided Relapse Prevention Programme in Schizophrenia: an extension of a mirror-design follow-up. Int J Clin Pract 2008 62 : 1943 6.
2. Lieberman JA, Stroup TS, McEvoy JP et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005 353 : 1209 23.
3. Tiihonen J, Walhbeck K, Lonnqvist J et al. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ 2006 333 : 224 7.
4. Jones PB, Barnes TR, Davies L et al. Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 2006 63 : 1079 87.
5. Kahn RS, Fleischhacker WW, Boter H et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 2008 371 : 1085 97.